Depression News and Research

Latest Depression News and Research

Antidepressants ineffective in Alzheimer’s: Study

According to a new study published in the medical journal The Lancet on Tuesday, two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness. Researchers urged doctors to think twice before prescribing these drugs to Alzheimer's patients with depression.

20 Jul 2011

Alzheimer’s risk reduced by healthy living: study

According to a new study leading a healthy lifestyle can help prevent Alzheimer's disease. Researchers said at Alzheimer's Association International Conference in Paris on Tuesday that the number of Alzheimer's cases could be cut in half if people exercise, eat well and stop smoking. Other risks include depression, high blood pressure, diabetes and obesity. Education is also a factor, because illiteracy keeps brains from developing properly. The new findings have been published in the journal Lancet Neurology.

20 Jul 2011

Latest advances in Alzheimer's research presented at AAIC 2011

This week, more than 5,000 scientists from around the world gathered in Paris to report the latest advances in Alzheimer's research at the Alzheimer's Association International Conference 2011.

20 Jul 2011

Women with breastfeeding difficulties may experience postpartum depression

Women who have breastfeeding difficulties in the first two weeks after giving birth are more likely to suffer postpartum depression two months later compared to women without such difficulties.

20 Jul 2011

Ventus Medical launches Provent Sleep Apnea Therapy in India

Ventus Medical is pleased to announce the Indian launch of its proprietary Provent Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea.

20 Jul 2011

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.

20 Jul 2011

People with small hippocampus do not face higher risk of depression

Imaging studies have repeatedly found that people with depression have smaller hippocampal volumes than healthy individuals. The hippocampus is a brain region involved in learning and memory, spatial navigation, and the evaluation of complex life situations or "contexts".

20 Jul 2011

Patients who use anti-depressants more likely to suffer relapses

Patients who use anti-depressants are much more likely to suffer relapses of major depression than those who use no medication at all, concludes a McMaster researcher.

20 Jul 2011

Teens with high positive well-being less likely to engage in unhealthy behaviors

Teenagers are known for their angst-ridden ways, but those who remain happy and positive during the tumultuous teenage years report better general health when they are adults, according to a new Northwestern University study.

19 Jul 2011

Insight into global incidence and prevalence of mild cognitive impairment

New research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.

19 Jul 2011

Simple lifestyle changes could prevent half of all Alzheimer's disease cases

Over half of all Alzheimer's disease cases could potentially be prevented through lifestyle changes and treatment or prevention of chronic medical conditions, according to a study led by Deborah Barnes, PhD, a mental health researcher at the San Francisco VA Medical Center.

19 Jul 2011

Online therapy programs revolutionise access to mental health services

A team of Macquarie University psychologists has developed a growing range of therapy programs that are being delivered online through the University’s new eCentreClinic.

19 Jul 2011

Simple eight-question survey can help predict depression, PTSD

A simple eight-question survey administered soon after injury can help predict which of the 30 million Americans seeking hospital treatment for injuries each year may develop depression or post-traumatic stress, report Therese S. Richmond, PhD, CRNP, associate professor at the University of Pennsylvania School of Nursing, and her colleagues in General Hospital Psychiatry.

19 Jul 2011

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced the formation of a majority owned subsidiary, NSVascular, Inc. and the signing of an exclusive license with the University of California, Los Angeles (UCLA) covering its medical applications of Thin-Film Nitinol (TFN) technology. Nitinol is a superelastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.

18 Jul 2011

AOA supports efforts to prevent traumatic brain injury in athletes

Hoping that amateur and professional sports leagues will follow a path similar to that of the National Football League with its recent tightening of rules surrounding head injuries, members of the American Osteopathic Association's (AOA) House of Delegates voted today to support efforts to prevent traumatic brain injury (TBI) in athletes at the school, sports club, and professional levels.

18 Jul 2011

Positive results from levomilnacipran Phase III study for major depressive disorder

Forest Laboratories, Inc. and Pierre Fabre Medicament today announced preliminary top-line results from a Phase III study of levomilnacipran for the treatment of adults with major depressive disorder (MDD).

18 Jul 2011

Landmark study may help prevent permanent brain injury in fighters

The Cleveland Clinic Lou Ruvo Center for Brain Health has launched a landmark study with professional fighters that will help determine whether magnetic resonance imaging (MRI) of the brain, along with other tests, can detect subtle changes in brain health that correlate with impaired thinking and functioning.

18 Jul 2011

QRxPharma seeks NDA approval for MoxDuo IR

QRxPharma Limited announced today initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the United States Food and Drug Administration (FDA). This NDA submission sets the stage for the regulatory approval process for MoxDuo IR for the treatment of moderate to severe acute pain, a $2.5 billion segment of the $8 billion spent annually on prescription opioids in the US.

18 Jul 2011

Study examines acute effects of low-dose alcohol on cardiac performance

Few studies have examined the acute effects of alcohol on myocardial or heart function. While moderate-to-high blood concentrations of alcohol acutely impair conventional echocardiographic measures of left ventricular (LV) performance, the effects of low concentrations are unclear.

16 Jul 2011

New antidepressant prescription linked to increased risk of falls in nursing home residents

Nursing home residents taking certain antidepressant medications are at an increased risk of falling in the days following the start of a new prescription or a dose increase of their current drug, according to a new study by the Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School.

16 Jul 2011